Matches in Nanopublications for { ?s ?p "[Molecular mechanisms of resveratrol (3,4,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- NP32467.RAG16VA_7iplBo5bB--gzf9shLixOiUiZ2yXibQBHfie8130_assertion description "[Molecular mechanisms of resveratrol (3,4,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP32467.RAG16VA_7iplBo5bB--gzf9shLixOiUiZ2yXibQBHfie8130_provenance.
- assertion description "[Molecular mechanisms of resveratrol (3,4,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Molecular mechanisms of resveratrol (3,4,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Molecular mechanisms of resveratrol (3,4,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP620549.RATPTNtSKvhi26poRuzUcInZ0D-hIGfWPB6IEoMN4eh_E130_assertion description "[Molecular mechanisms of resveratrol (3,4,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP620549.RATPTNtSKvhi26poRuzUcInZ0D-hIGfWPB6IEoMN4eh_E130_provenance.
- NP620550.RAQhJZnNMS4CkSp3-sXx8vavbltuWblgZxxqoZUZ5RmEQ130_assertion description "[Molecular mechanisms of resveratrol (3,4,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP620550.RAQhJZnNMS4CkSp3-sXx8vavbltuWblgZxxqoZUZ5RmEQ130_provenance.
- NP32915.RAGIxV9xE7_cTS7Ib17acw0aUW5iVWmoAEAe_jUKuQIaI130_assertion description "[Molecular mechanisms of resveratrol (3,4,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP32915.RAGIxV9xE7_cTS7Ib17acw0aUW5iVWmoAEAe_jUKuQIaI130_provenance.
- NP804219.RAPUUtuNbpRHjMoamOoOgDKb5A-VMW-FWAK9WbF8Ixjy4130_assertion description "[Molecular mechanisms of resveratrol (3,4,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP804219.RAPUUtuNbpRHjMoamOoOgDKb5A-VMW-FWAK9WbF8Ixjy4130_provenance.
- NP804163.RA5hHtqncLjjGDI_j4qPuOtqvhNA8lk1sGe36cCwuSzcM130_assertion description "[Molecular mechanisms of resveratrol (3,4,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP804163.RA5hHtqncLjjGDI_j4qPuOtqvhNA8lk1sGe36cCwuSzcM130_provenance.
- NP20221.RAzV5sykWd3v04un_UWlQnTBwtkCP15a4nJHKXOlf8RNs130_assertion description "[Molecular mechanisms of resveratrol (3,4,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP20221.RAzV5sykWd3v04un_UWlQnTBwtkCP15a4nJHKXOlf8RNs130_provenance.